De Luca Giampiero,Ythier Arnaud,Munafo Alain,Lopez-Bresnahan Maria
申请号：
SI200532191
公开号：
SI2805723T1
申请日:
2005.12.20
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remiuing multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.
